(Q28277029)

English

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial (English)

0 references

0 references

invasive aspergillosis

1 reference

based on heuristic

inferred from title

Raoul Herbrecht

object named as

Raoul Herbrecht

10

0 references

23

object named as

John R Perfect

0 references

1

object named as

Thomas J Walsh

0 references

Thomas F Patterson

3

object named as

Thomas F Patterson

0 references

14

object named as

Brahm H Segal

0 references

Gerald R Donowitz

5

object named as

Gerald R Donowitz

0 references

9

object named as

Susan Hadley

0 references

Patricia Ribaud

13

object named as

Patricia Ribaud

0 references

Pranatharthi Chandrasekar

4

object named as

Pranatharthi Chandrasekar

0 references

Jo-Anne H. Young

16

object named as

Jo-Anne H van Burik

0 references

2

object named as

Issam Raad

0 references

12

object named as

Arnold Louie

0 references

author name string

Richard Graybill

6

0 references

Reginald E Greene

7

0 references

Ray Hachem

8

0 references

Amelia Langston

11

0 references

David A Stevens

15

0 references

Charles S White

17

0 references

Gavin Corcoran

18

0 references

Jagadish Gogate

19

0 references

Gopal Krishna

20

0 references

Lisa Pedicone

21

0 references

Catherine Hardalo

22

0 references

language of work or name

0 references

publication date

1 January 2007

0 references

number of pages

11

1 reference

based on heuristic

inferred from page(s)

Clinical Infectious Diseases

0 references

44

0 references

1

0 references

2-12

0 references

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Aspergillosis. Pathogenesis, clinical manifestations, and therapy

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Efficacy of posaconazole in a murine model of central nervous system aspergillosis

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Activity of posaconazole combined with amphotericin B against Aspergillus flavus infection in mice: comparative studies in two laboratories

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Efficacy of SCH56592 in a rabbit model of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Disposition of posaconazole following single-dose oral administration in healthy subjects

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Voriconazole: therapeutic review of a new azole antifungal

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Aspergillus nidulans Infection in Chronic Granulomatous Disease

1 reference

https://api.crossref.org/works/10.1086%2F508774

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28277029&oldid=2106967680"